Related Experiment Video
Updated: Jun 3, 2025
07:44
Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay
Published on: March 12, 2018
10.0K
Molecular Detection of Lymph Node Metastases with One-Step Nucleic Acid Amplification (OSNA) Pooling in Prostate
Mercè Cuadras1,2, Maria E Semidey3, Jacques Planas1,2
1Urology Department, Vall d'Hebron University Hospital, 08035 Barcelona, Spain.
International Journal of Molecular Sciences
|January 8, 2025
Summary
One-Step Nucleic Acid Amplification (OSNA) offers a reliable alternative to traditional hematoxylin and eosin (H&E) staining for detecting prostate cancer lymph node metastases. This method demonstrates high concordance and accuracy in pathological lymph node staging.
Area of Science:
- Urology
- Oncology
- Pathology
Background:
- Pelvic lymph node dissection (PLND) is crucial for staging prostate cancer (PCa).
- Current gold standard, hematoxylin and eosin (H&E) staining, may miss small metastases.
- One-Step Nucleic Acid Amplification (OSNA) allows entire lymph node (LN) analysis via CK19 mRNA detection.
Purpose of the Study:
- To compare the postoperative performance of OSNA pooling versus conventional H&E staining for pathological LN detection in PCa patients.
- To evaluate OSNA's accuracy in identifying lymph node metastases.
Main Methods:
- Observational, prospective, multicenter study (POPCORN).
- Analysis of 2503 LNs from 131 PCa patients undergoing PLND.
- Comparison of OSNA pooling and H&E staining for LN evaluation.
Main Results:
- High concordance (93.9%) between OSNA pooling and H&E staining.
- OSNA pooling showed high specificity (96.6%) and negative predictive value (96.6%).
- Agreement measured by Cohen's Kappa (κ) was 0.70, with only 6.1% discordances.
Conclusions:
- OSNA pooling demonstrates high concordance with H&E staining for detecting lymph node metastases in PCa.
- OSNA pooling presents a viable alternative to H&E staining for accurate pathological LN staging.
- This method may improve the detection of small metastatic foci in prostate cancer.
